From: Clinical review: Specific aspects of acute renal failure in cancer patients
Pre-renal failure | Sepsis |
---|---|
Ā | Extracellular dehydration (diarrhoea, mucitis, vomiting) |
Ā | Sinusoidal obstruction syndrome (formerly called hepatic veno-occlusive disease) |
Ā | Drugs (e.g., calcineurin inhibitors, ACE inhibitors, NSAIDs) |
Ā | Capillary-leak syndrome (IL2) |
Intrinsic failure | Ā |
āāāAcute tubular necrosis | Ischaemia (shock, severe sepsis) |
Ā | Nephrotoxic agents (contrast agents, aminoglycosides, amphotericin, ifosfamide, cisplatin) |
Ā | Disseminated intravascular coagulation |
Ā | Intravascular haemolysis |
āāāAcute interstitial nephritis | Immuno-allergic nephritis |
Ā | Pyelonephritis |
Ā | Cancer infiltration (e.g., lymphoma, metastasis) |
Ā | Nephrocalcinosis |
āāāVascular nephritis | Thrombotic microangiopathy |
Ā | Vascular obstruction |
āāāGlomerulonephritis | Amyloidosis (AL, myeloma; AA, renal carcinoma or Hodgkin's disease) |
Ā | Immunotactoid glomerulopathy |
Ā | Membranous glomerulonephritis (pulmonary, breast or gastric carcinoma) |
Ā | IgA glomerulonephritis, focal glomerulosclerosis |
Post-renal failure | Intra-renal obstruction (e.g., urate crystals, light chain, acyclovir, methotrexate) |
Ā | Extrarenal obstruction (retroperitonal fibrosis, ureteral or bladder outlet obstruction) |